Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

11 Feb 2021 07:00

RNS Number : 6888O
Checkit PLC
11 February 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

 

11 February 2021

 

Checkit plc

("Checkit" or the "Group")

 

Trading update

 

The Group provides a trading update for the financial year ended 31 January 2021. A summary of the Group's unaudited revenue is as follows:

 

REVENUES (UNAUDITED) (£m)

Three months to

Twelve months to

 

 

 

31 Jan

2021 Actual

31 Jan

2020 Actual

Change

%

31 Jan

2021 Actual

31 Jan

2020 Actual

31 Jan 2020

Normalised*

Change Normalised*

%

Checkit Connect:

Recurring

1.5

1.0

+51%

5.1

3.2

3.9

+33%

Non-recurring

0.2

0.6

(54) %

1.6

1.6

2.1

(23) %

Total Checkit Connect

1.7

1.6

+6%

6.7

4.8

6.0

+13%

Total Checkit BEMS

1.7

1.6

+2%

6.5

5.0

6.8

(5) %

  Non - recurring

Total Group

3.4

3.2

+6%

13.2

9.8

12.8

+3%

 

* Normalised sales illustrate sales that would have been included in the Group's financial results had Checkit UK Limited, which was acquired on 14 May 2019, been owned by the Group throughout both periods.

 

The business performed above the Board's expectations during Q4.

 

The Board believes that the Group's operating result for FY21 will be around 15% better than current market estimates (prior to any adjustment related to prior year re-statement).

 

Checkit Connect recurring revenues for Q4 grew 51% compared to the same period in the prior year, and closed FY21 at £5.1m (+33% compared to prior year).

 

Annual recurring revenue (ARR) grew by 46% to close at £5.7m (FY20 £3.9m), reflecting the increase in annualised contracted Revenues achieved during the year.

 

These results are in line with trends announced previously and reflect a combination of additional subscribers, price increases and a continued programme of converting existing maintenance contracts to subscription-based income during the year.

 

Checkit Connect non-recurring revenue declined compared to FY20 due to the conversion of maintenance contracts to subscription income, timing differences on Q4 Healthcare installations due to the UK's national roll out of the COVID-19 vaccine program and H1 pandemic related field service challenges.

 

Checkit BEMS experienced a stabilisation of its revenue in Q4 as construction activity returned following the challenges of COVID-19 restrictions in H1. The business unit saw a revenue decline of 5% in FY21 due to the pandemic related challenges in the first half of the year.

 

Cash

Cash as of 31 January 2021 was £11.5m (31 January 2020: £14.3m; 31 July 2020: £13.4m).

 

 

Outlook

Following the announcement on 4 February 2021 regarding the acquisition of Tutela LLC and recruitment of two key senior hires, the Board is accelerating its growth plans in both Europe and in the US. This includes increasing investment in sales and marketing in FY22 designed to maximise subscriber volumes on the back of digital transformation trends which the Board believes will serve to accelerate ARR growth.

 

Restatement of prior year financial statements

Following the qualified Audit opinion in FY20, the Board revisited the assumptions made regarding its decision to fully impair the intangible assets in the FY20 financial statements due to the unforeseen impact of COVID-19.

In light of the resilient business performance, the group carried out a thorough impairment review of all balances related to the qualified audit opinion. From the work performed the Board has agreed with its auditors Grant Thornton that an adjustment should be made to restate FY20 financial statements.

The adjustment will result in an increase in intangible assets carried forward at 31 January 2020 and a reduction in the reported operating loss from continued operations. The full impact of restatement will be shared as part of the preliminary results announcement expected to be issued on 29 April 2021. These are non-cash accounting entries and so will have no effect on underlying profitability or cash position of the Group.

Forward looking statements

This document contains forward looking statements with respect to the business, strategy and plans of Checkit plc and its current goals and expectations relating to its future financial condition and performance. Statements that are not historical facts, including statements about Checkit or management's beliefs and expectations, are forward looking statements. By their nature, forward looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. Checkit's actual future results may differ materially from the results expressed or implied in these forward-looking statements as a result of a variety of factors among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. The forward-looking statements contained in this document are made as of the date hereof, and Checkit undertakes no obligation to update any of its forward-looking statements.

 

 Checkit plc +44 (0) 1223 371000

 www.checkit.net

 Keith Daley (Executive Chair)

 Aylsa Muir (Chief Financial Officer)

 

 N+1 Singer (Nominated Adviser & Broker) +44 (0) 20 7496 3000

 Shaun Dobson / George Tzimas (Corporate Finance)

 Rachel Hayes (Corporate Broking)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVBLFFFLLXBBV
Date   Source Headline
26th May 20207:00 amRNSCOVID-19 Update and Change to Results Date
5th May 20205:03 pmRNSResignation of Director
21st Apr 20203:20 pmRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSCOVID-19 Update
23rd Mar 20206:11 pmRNSDirector/PDMR Shareholding
18th Mar 20205:15 pmRNSDirector/PDMR Shareholding
21st Feb 20204:41 pmRNSSecond Price Monitoring Extn
21st Feb 20204:35 pmRNSPrice Monitoring Extension
21st Feb 20207:00 amRNSDirector/PDMR Shareholding
14th Feb 20207:00 amRNSPDMR Dealing and Concert Party Holdings
13th Feb 20207:00 amRNSTrading Update
3rd Feb 20207:00 amRNSAppointment of Non-Executive Director
23rd Dec 20195:05 pmRNSHolding(s) in Company
18th Dec 20196:25 pmRNSPDMR Dealings
16th Dec 201911:40 amRNSResignation of Director
13th Dec 20194:27 pmRNSHolding(s) in Company
11th Dec 20196:08 pmRNSHolding(s) in Company
10th Dec 20195:18 pmRNSDirector/PDMR Shareholding
10th Dec 20199:47 amRNSDirector Dealings and Related Party Transactions
9th Dec 20194:30 pmRNSHolding(s) in Company
3rd Dec 20192:48 pmRNSCompletion of Tender Offer & Total Voting Rights
26th Nov 20197:00 amRNSResult of Tender Offer
25th Nov 20192:00 pmRNSResult of General Meeting
1st Nov 20197:00 amRNSProposed Tender Offer and Notice of GM
31st Oct 20195:17 pmRNSDirector/PDMR Shareholding
31st Oct 20199:57 amRNSContract Win
28th Oct 20197:00 amRNSHolding(s) in Company
24th Oct 20197:00 amRNSTotal Voting Rights
23rd Oct 20195:06 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHalf-year Report
2nd Oct 20195:15 pmRNSChange of Name
25th Sep 20197:00 amRNSCompletion of Sale of Elektron Technology
3rd Sep 20191:14 pmRNSElektron Technology UK Limited - Disposal update
13th Aug 20194:30 pmRNSDirector/PDMR Shareholding
31st Jul 20192:05 pmRNSSecond Price Monitoring Extn
31st Jul 20192:00 pmRNSPrice Monitoring Extension
31st Jul 20197:00 amRNSSale of Elektron Technology UK Limited
30th Jul 20193:30 pmRNSResult of AGM
5th Jul 20197:00 amRNSPosting of Annual Report & Notice of AGM
19th Jun 20195:02 pmRNSHolding(s) in Company
12th Jun 20197:00 amRNSPreliminary Results
15th May 20197:00 amRNSTrading Update & Notice of Results
15th May 20197:00 amRNSAcquisition
5th Feb 20197:00 amRNSTrading and Strategic Update
18th Dec 20189:05 amRNSBoard Changes
1st Nov 20187:00 amRNSTrading Statement
10th Oct 20181:26 pmRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
28th Aug 20189:55 amRNSHolding(s) in Company
10th Aug 20189:19 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.